“It is shocking to see that 30% to 40% of the higher-risk populations — at least for elderly, and I think it’s a similar number for immunocompromised — are getting the updated vaccine,” said advisory committee member Dr. Camille Kotton, clinical director of transplant and immunocompromis...
“It is shocking to see that 30% to 40% of the higher-risk populations — at least for elderly, and I think it’s a similar number for immunocompromised — are getting the updated vaccine,” said advisory committee member Dr. Camille Kotton, clinical director of transplant and immunocomprom...